Faeth Therapeutics (FTH) Live Share Price, Invest From India

Faeth Therapeutics Stock Performance

as on October 31, 2026 at 2:15 pm IST

Day's Low
Day's High
$17.88
Day's Price Range
$19.04
$18.69
4.33%
Downside
1.87%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$18.69
100.00%
Downside
-100.00%
Upside

Faeth Therapeutics share price movements today

Previous Close: $18.75
Open: $18.07
Volume: 930.5K
Market Cap: $496.1M
Day's Low - High: $17.88 - $19.04

Faeth Therapeutics Historical Returns

1 Month Return: -36.95 %
3 Month Return: -34.94 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Faeth Therapeutics Stock Fundamentals & Key Indicators

Check Faeth Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$496.1M

EPS (TTM)

-141.65

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.14

Industry PE ratio

-7.60

PEG Ratio

0.00

EBITDA

-195.4M

Revenue (TTM)

-4.9M

Profit Margin

2740.82%

Return On Equity TTM

-192.76%

Faeth Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Faeth Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Faeth Therapeutics	StrongBuy	$496.1M	NA	-0.14	2740.82%	0.00%
Moderna	Neutral	$85.5B	-35.47%	-26.84	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Analyst Recommendation on Faeth Therapeutics Stock

Based on 11 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 11 analysts, 100% of analysts recommend a 'BUY' rating for Faeth Therapeutics. Average target price of $56.6

Faeth Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Faeth Therapeutics.

Current Price

$18.69

Analyzed by

11 Analysts

High

$70

Low

$40

Faeth Therapeutics target price $0, a slight upside of 0% compared to current price of $18.69. According to 11 analysts rating.

Indian Investors' Interest in Faeth Therapeutics Stock

Search interest for Faeth Therapeutics Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 1, 2026 to October 31, 2026

Change:-7% versus previous 30 day period

Faeth Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-4	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	-132	-
Operating Income	-8	-7	-7	-7	-7	-5	-4	-4	-170	-18
EBITDA	-7	-6	-6	-7	-6	-4	-4	-4	-170	-15
Interest Expense	0	0	0	0	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-7	-7	-6	-4	-4	-4	-170	-16
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-7	-7	-7	-6	-4	-4	-4	-170	-16
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Faeth Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-1	0	0	-
Operating Income	-12	-12	-19	-37	-49	-37	-31	-22
EBITDA	-12	-14	-18	-35	-47	-35	-28	-20
Interest Expense	0	2	1	0	0	0	0	0
Depreciation	0	0	0	0	1	1	1	0
Income Before Tax	-13	-16	-20	-36	-48	-34	-30	-21
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-13	-16	-20	-36	-48	-34	-30	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Faeth Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-7	-7	-7	-6	-4	-4	-4	-170	-16
Operating Cash Flow	-7	-5	-5	-5	-7	-5	-3	-3	-10	-15
Investing Cash Flow	5	6	12	-3	7	8	1	2	-31	-108
Financing Cash Flow	0	0	0	0	0	0	0	0	185	-1
Change in Cash	-2	0	7	-9	0	2	-1	-1	143	-125

Faeth Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-13	-16	-20	-36	-48	-34	-30	-21
Operating Cash Flow	-10	-8	-17	-30	-39	-32	-24	-20
Investing Cash Flow	0	0	-1	-143	49	38	22	19
Financing Cash Flow	0	8	35	163	0	-11	0	0
Change in Cash	-9	0	16	-9	10	-4	-3	-1

Global Institutional Holdings in Faeth Therapeutics

Check out the Institutions with significant holdings in Faeth Therapeutics.

Funds	Holdings
Felix Baker	4.98%
Vanguard	3.59%
Peter Harwin	2.79%
Peter Kolchinsky	2.79%
Michael Rockefeller	1.40%

See all

Faeth Therapeutics News & Key Events

Insights on Faeth Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 615.7%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 161.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, FTH stock has moved down by -37.0%

About Faeth Therapeutics

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]

Organisation	Faeth Therapeutics
Headquarters	1405 Research Blvd, Rockville, MD, 20850, US
Industry	Biotechnology
CEO	Anand Parikh

Key Management of Faeth Therapeutics

Name	Title
Mr. Josiah Craver CPA	Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer
Dr. Scott W. Lowe Ph.D.	Scientific Co-Founder
Mr. Oliver Maddocks Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Lewis clayton Cantley Ph.D.	Scientific Co-Founder
Dr. Gregory J. Hannon Ph.D.	Scientific Co-Founder
Dr. Karen H. Vousden Ph.D.	Scientific Co-Founder & Director
Dr. Benjamin Hopkins Ph.D.	Scientific Co-Founder
Mr. Christopher W. Gerry J.D.	General Counsel & Secretary
Mr. Anand Parikh Esq., J.D.	CEO, President & Chair
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.	Scientific Co-Founder

FAQs

What is Faeth Therapeutics share price today?

Faeth Therapeutics share price today is $18.69 as on October 31, 2026 at 8:45 am IST at the close of the market. Faeth Therapeutics share today touched a day high of $19.04 and a low of $17.88.

What is the 52 week high and 52 week low for Faeth Therapeutics share?

Faeth Therapeutics share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Faeth Therapeutics stock price today i.e. October 31, 2026 at 8:45 am IST is closed at $18.69,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Faeth Therapeutics's market capitalisation today?

Faeth Therapeutics market capitalisation is $0.00T as on October 31, 2026 at 8:45 am IST.

How to invest in Faeth Therapeutics Stock (FTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Faeth Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Faeth Therapeutics Stock (FTH) from India?

Indian investors can start investing in Faeth Therapeutics (FTH) shares with as little as ₹94.94999694824219 or $1 (as of October 31, 2026 at 7:28 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Faeth Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 31, 2026 at 7:28 pm IST). Based on Faeth Therapeutics share’s latest price of $18.69 as on October 31, 2026 at 8:45 am IST, you will get 0.5350 shares of Faeth Therapeutics. Learn more about fractional shares .